Related Experiment Video

Updated: Oct 3, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Congenital nemaline myopathy due to ACTA1-gene mutation and carnitine insufficiency: a case report

H Buxmann1, R Schlösser, W Schlote

  • 1Department of Paediatrics, University Hospital Frankfurt/Main, Germany.

Neuropediatrics
|December 19, 2001
PubMed

Insights

Carnitine deficiency may contribute to nemaline myopathy, a genetic muscle disorder. Supplementation improved a premature infant's motor skills, suggesting a link between carnitine metabolism and disease progression.

Area of Science:

  • Genetics
  • Neurology
  • Metabolic Disorders

Background:

  • Nemaline myopathy is a heterogeneous genetic muscle disorder with poorly understood pathogenesis.
  • Congenital nemaline myopathy, particularly ACTA1-gene mutations, presents unique challenges in understanding muscle weakness.
  • Carnitine metabolism disturbances are being explored as a potential factor in muscle disorders.

Observation:

  • A premature infant with congenital nemaline myopathy (ACTA1 mutation) exhibited low carnitine levels at 8 weeks of age.
  • Following oral carnitine supplementation, the infant showed significant gradual improvement in motor development.
  • By 15 months, the child achieved normal carnitine levels without supplementation and demonstrated substantial motor milestones.

Findings:

  • Carnitine deficiency may be associated with congenital nemaline myopathy.
  • Carnitine supplementation can lead to clinical improvement in affected infants.
  • Restoration of normal carnitine levels correlates with improved motor function.

Implications:

  • Carnitine metabolism warrants further investigation in nemaline myopathy patients.
  • Understanding carnitine's role could elucidate the pathogenesis of muscle weakness in nemaline myopathy.
  • This case highlights the potential therapeutic benefit of carnitine in specific congenital myopathies.

More Related Videos

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...